Figure 2.
Immunological characterization and immunotherapeutic strategies in CCA. Schematic representation of the innate immune cells promoting tumor growth (left part of the balance) in comparison with the adaptive immune cells implicated in the tumor growth control. Abbreviations: COX2: Cyclooxygenase 2; CTLA-4: Cytotoxic T-lymphocyte antigen 4; IDO: indoleamine 2,3-dioxygenase; IFNγ: Interferon γ; IL-10: Interleukin 10; MDSC: Myeloid-derived suppressor cell; TAM: Tumor-associated macrophage; TAN: Tumor-associated neutrophil; TGF-β Transforming growth factor beta; PD-1: Programmed death 1; PD-L1: Programmed death ligand 1.
